News

Power3 Medical Products, Inc. has discovered a group of breast cancer protein biomarkers in preliminary studies of blood serum.

This patent establishes protection around the company's innovative linear, isothermal RNA amplification technology.

Agreement strengthens febit’s IP and places febit in a position to successfully market Geniom® worldwide.

GeneBio’s Phenyx is a software platform for the identification and characterization of proteins and peptides from mass spectrometry data.

After 11 years as The Society for Biomolecular Screening, members have voted and approved the new name “Society for Biomolecular Sciences.”

Celera Diagnostics evaluated DNA samples from 3,000 individuals in three studies to compare patterns of genetic variation in people with a history of MI to those with no history of CHD. The results were replicated in all three studies.

Alnylam and Isis announce a co-exclusive license agreement with Stanford University.

Microscopic particles possess both the right size to gain entry into cells and also the right structure to carry other therapeutic strands of RNA inside with them.

In the first phase of the project, the MPI researchers will genotype a large sample set using Illumina's Sentrix Human-1 BeadChip.

The Applied Biosystems 1700 Analyzer is very sensitive and provides good correlation between the gene expression patterns, using it with the TaqMan assays.